Chapter

Introduction of HPV prophylactic vaccination

Loretta Brabin

in Vaccines for the Prevention of Cervical Cancer

Published on behalf of Oxford University Press

ISBN: 9780199543458
Published online May 2011 | e-ISBN: 9780199607181 | DOI: http://dx.doi.org/10.1093/med/9780199543458.003.0009

Series: Oxford Oncology Library

Introduction of HPV prophylactic vaccination

Show Summary Details

Preview

• Vaccine introduction requires complex decision making across a range of epidemiological, cost, social, and health system dimensions, and is a country-specific process. • Countries currently introducing human papilloma virus (HPV) vaccination target different age groups and use various delivery models. • HPV vaccine acceptance is expected to be high in Western countries, provided parents’ concerns about safety and sexual risks are adequately addressed. • Informed consent of adolescents should be a priority since vaccine acceptance is only the first step towards cervical cancer prevention. • Delivery of HPV vaccines is feasible and could provide a platform for future adolescent vaccines and improved preventive care for this age group.

Chapter.  3832 words.  Illustrated.

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.